Jonathan D Brodie

This inventor holds 11 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Brookhaven Science Associates, Lcc, Catalyst Pharmaceutical Partners, Inc., New York University. Active years: 2000-2016.

USPTO Granted Patents = 11 (Patent Applications = 1)

% Patents Active = 63.6

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 3.0

ph-index = 6

Forward Citations = 136(Granted Patents)

Location History:

Cos Cob, CT (US) (2000 - 2005)
Old Greenwich, CT (US) (2016)

Company Filing History:

10 out of 351

Brookhaven Science Associates, Lcc

patents

1 out of 2

Catalyst Pharmaceutical Partners, Inc.

The Feinstein Institutes for Medical Research

patents

where one patent can have more than one assignee

Years Active: 2000-2016

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9254274 - Method of treating Tourette'S disorder with GABA-aminotransferase inactivators (2016-02-09),

2. 6939876 - Prevention of addiction in pain management (2005-09-06),

3. 6906099 - Treatment of addiction and addiction-related behavior using a composition of topiramate (2005-06-14),

4. 6890951 - Treatment of addiction and addiction-related behavior (2005-05-10),

5. 6828349 - Treatment of addiction and addiction-related behavior (2004-12-07),

6. 6593367 - Treatment of addiction and addiction-related behavior (2003-07-15),

7. 6541520 - Treatment of addiction and addiction-related behavior (2003-04-01),

8. 6462084 - Treatment for obsessive-compulsive disorder (OCD) and OCD-related disorders using GVG (2002-10-08),

9. 6395783 - Treatment of PCP addiction and PCP addiction-related behavior (2002-05-28),

10. 6323239 - Treatment of addiction to ethanol and addictive-related behavior (2001-11-27),

11. 6057368 - Treatment of addiction and addiction-related behavior (2000-05-02),

Title: **Jonathan D Brodie: A Trailblazer in Medical Innovations**

Introduction

Jonathan D Brodie is a prominent inventor based in Cos Cob, CT, who has made significant contributions to the field of medical innovations. With a portfolio containing 11 patents, his work primarily focuses on treatments for neurological disorders and pain management.

Latest Patents

Among his notable inventions, Jonathan's latest patents include a method for treating Tourette's Disorder using GABA-aminotransferase inactivators. This groundbreaking method employs GABAergic drugs that elevate the presynaptic GABA levels without significantly increasing GABA tone in the brain, thereby offering a novel approach to managing this complex disorder. Another significant patent addresses the prevention of addiction in pain management through a composition that combines a pharmaceutically acceptable analgesic with a GABAergic agent, effectively reducing the addictive liability typically associated with pain relief medications.

Career Highlights

Throughout his career, Jonathan D Brodie has worked with reputable organizations, including Brookhaven Science Associates, LLC and Catalyst Pharmaceutical Partners, Inc. His substantial contributions to these companies have helped advance research and applications related to neurology and pain management.

Collaborations

Jonathan has collaborated with notable professionals in the field, such as Stephen L Dewey and Charles R Ashby, Jr. These partnerships have facilitated the development of innovative solutions and have furthered research endeavors aimed at addressing significant health challenges.

Conclusion

Jonathan D Brodie remains a key figure in the realm of medical innovations, particularly concerning neurological treatments and pain management solutions. His dedication to advancing healthcare through research and invention continues to impact the medical community positively. As he forges ahead with his work, the future of his contributions promises to bring about meaningful changes in the lives of those affected by various medical conditions.